Explain That Biosimilars are not Exact Generic Equivalents

October 2015

You may get questions about "biosimilars"...due to the launch of the FIRST biosimilar, Zarxio (zar-zee-oh, filgrastim-sndz).

Zarxio is a biosimilar for Neupogen. Expect to also see biosimilars for Epogen, Humira, and Remicade in the next few years.

Be ready to answer common questions about biosimilars.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote